136 related articles for article (PubMed ID: 10604591)
21. Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.
Kobayashi M; Natsume T; Tamaoki S; Watanabe J; Asano H; Mikami T; Miyasaka K; Miyazaki K; Gondo M; Sakakibara K; Tsukagoshi S
Jpn J Cancer Res; 1997 Mar; 88(3):316-27. PubMed ID: 9140117
[TBL] [Abstract][Full Text] [Related]
22. Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.
Harrigan GG; Luesch H; Yoshida WY; Moore RE; Nagle DG; Paul VJ; Mooberry SL; Corbett TH; Valeriote FA
J Nat Prod; 1998 Sep; 61(9):1075-7. PubMed ID: 9748368
[TBL] [Abstract][Full Text] [Related]
23. Marine Antitumor Peptide Dolastatin 10: Biological Activity, Structural Modification and Synthetic Chemistry.
Gao G; Wang Y; Hua H; Li D; Tang C
Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34202685
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antiproliferative activity of a cyclic analog of dolastatin 10.
Poncet J; Hortala L; Busquet M; Guéritte-Voegelein F; Thoret S; Pierré A; Atassi G; Jouin P
Bioorg Med Chem Lett; 1998 Oct; 8(20):2855-8. PubMed ID: 9873636
[TBL] [Abstract][Full Text] [Related]
25. Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay.
Aherne GW; Hardcastle A; Valenti M; Bryant A; Rogers P; Pettit GR; Srirangam JK; Kelland LR
Cancer Chemother Pharmacol; 1996; 38(3):225-32. PubMed ID: 8646796
[TBL] [Abstract][Full Text] [Related]
26. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening.
Enyedy IJ; Ling Y; Nacro K; Tomita Y; Wu X; Cao Y; Guo R; Li B; Zhu X; Huang Y; Long YQ; Roller PP; Yang D; Wang S
J Med Chem; 2001 Dec; 44(25):4313-24. PubMed ID: 11728179
[TBL] [Abstract][Full Text] [Related]
27. Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.
Luesch H; Moore RE; Paul VJ; Mooberry SL; Corbett TH
J Nat Prod; 2001 Jul; 64(7):907-10. PubMed ID: 11473421
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
Mohammad RM; Varterasian ML; Almatchy VP; Hannoudi GN; Pettit GR; Al-Katib A
Clin Cancer Res; 1998 May; 4(5):1337-43. PubMed ID: 9607595
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships.
Mezö I; Lovas S; Pályi I; Vincze B; Kálnay A; Turi G; Vadász Z; Seprödi J; Idei M; Tóth G; Gulyás E; Otvös F; Mák M; Horváth JE; Teplán I; Murphy RF
J Med Chem; 1997 Oct; 40(21):3353-8. PubMed ID: 9341910
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and antitumor activity evaluation of pretubulysin analogs.
Xu X; Fan M; Qi J; Yao L
Chem Biol Drug Des; 2021 Sep; 98(3):341-351. PubMed ID: 33930251
[TBL] [Abstract][Full Text] [Related]
31. Interaction of marine toxin dolastatin 10 with porcine brain tubulin: competitive inhibition of rhizoxin and phomopsin A binding.
Li Y; Kobayashi H; Hashimoto Y; Shirai R; Hirata A; Hayashi K; Hamada Y; Shioiri T; Iwasaki S
Chem Biol Interact; 1994 Dec; 93(3):175-83. PubMed ID: 7923438
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of novel 6-substituted amino-9-(β-d-ribofuranosyl)purine analogs and their bioactivities on human epithelial cancer cells.
Tuncbilek M; Kucukdumlu A; Guven EB; Altiparmak D; Cetin-Atalay R
Bioorg Med Chem Lett; 2018 Feb; 28(3):235-239. PubMed ID: 29326016
[TBL] [Abstract][Full Text] [Related]
33. Antineoplastic Agents. 603. Quinstatins: Exceptional Cancer Cell Growth Inhibitors.
Pettit GR; Melody N; Chapuis JC
J Nat Prod; 2017 Mar; 80(3):692-698. PubMed ID: 28211277
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and Biological Evaluation of Novel Triazoles Linked 7-hydroxycoumarin as Potent Cytotoxic Agents.
Farooq S; Hussain A; Qurishi MA; Hamid A; Koul S
Anticancer Agents Med Chem; 2018; 18(11):1531-1539. PubMed ID: 29298653
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, Cytotoxicity and Antioxidant Activity of New Analogs of RC-121 Synthetic Derivatives of Somatostatin.
Naydenova E; Wesselinova D; Staykova S; Goshev I; Vezenkov L
Anticancer Agents Med Chem; 2018; 18(10):1417-1424. PubMed ID: 29667555
[TBL] [Abstract][Full Text] [Related]
36. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
[TBL] [Abstract][Full Text] [Related]
37. 1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: Anti-cancer agents that target nucleophosmin 1 (NPM1).
Penthala NR; Ketkar A; Sekhar KR; Freeman ML; Eoff RL; Balusu R; Crooks PA
Bioorg Med Chem; 2015 Nov; 23(22):7226-33. PubMed ID: 26602084
[TBL] [Abstract][Full Text] [Related]
38. Indole carboxylic acid esters of melampomagnolide B are potent anticancer agents against both hematological and solid tumor cells.
Bommagani S; Ponder J; Penthala NR; Janganati V; Jordan CT; Borrelli MJ; Crooks PA
Eur J Med Chem; 2017 Aug; 136():393-405. PubMed ID: 28525840
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
40. Dolastatin 11, a marine depsipeptide, arrests cells at cytokinesis and induces hyperpolymerization of purified actin.
Bai R; Verdier-Pinard P; Gangwar S; Stessman CC; McClure KJ; Sausville EA; Pettit GR; Bates RB; Hamel E
Mol Pharmacol; 2001 Mar; 59(3):462-9. PubMed ID: 11179440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]